Table 1.
Primary TM cell line | Age | Sex | Race | Passages | Ocular disease(s) |
NTM 2252 OS | 73 | M | NS | 3–6 | None |
NTM G1 | 66 | F | African American | 5–8 | None |
NTM 1848 OD | 43 | M | African American | 3–7 | None |
NTM 17–3431 | 55 | F | Caucasian | 5–8 | None |
NTM 8467 | 56 | M | Caucasian | 5–8 | None |
NTM 895–03 | 63 | F | NS | 7–9 | None |
NTM 8055 | 53 | M | Caucasian | 3–7 | None |
GTM 1096 | 99 | M | Caucasian | 4–7 | Glaucoma |
GTM 1480 OD | 70 | M | Caucasian | 4–8 | Glaucoma |
GTM 1480 OS | 70 | M | Caucasian | 4–8 | Glaucoma |
GTM 3817 OD | 68 | F | Caucasian | 3–6 | Glaucoma |
GTM 3817 OS | 68 | F | Caucasian | 3–6 | Glaucoma |
GTM 28462 | 74 | M | Caucasian | 4–6 | Glaucoma |
GTM 7600 | 96 | F | Caucasian | 4–7 | Glaucoma |
Primary SC cell line | |||||
SC 14 | 14 | F | Caucasian | 3–6 | None |
SC 24 | 24 | M | Caucasian | 3–6 | None |
SC 48 | 48 | F | Caucasian | 3–6 | None |
F, female; M, male; NS, not specified.